Posted on 09/02/2009 in Pharmacy Supplier News Proctor & Gamble (P&G) may sell either of its Duracell, Iams or Pringles brands - but not now, an expert has claimed.
A recent article in the Financial Times (FT) discussed P&G's current position and its decision to find buyers for its pharmaceuticals arm.
The group has "long debated" whether to sell any of the aforementioned brands but one sector commentator said the "methodical" company thinks now is not the ideal time to do so.
The newspaper said while Duracell was potentially a large and therefore "unwieldy" purchase for private equity firms, consolidation in the pet food sector makes the number of possible Iams buyers limited.
In addition, any new owner of Pringles would face competition from "industry giant" and PepsiCo-owned Frito-Lay, the FT added.
P&G recently announced that net sales for 2008 topped those of the previous year and totalled $83,503 million (55,981 million pounds).
Operating income rose to $17,083 and net earnings per common share went up from $3.22 to $3.86.
Other news stories from 09/02/2009
Read more in the Zenopa News Archive
How this news is generated
|
